Copaxone in therapy of remittent disseminated sclerosis patients

Twenty three remittent disseminated sclerosis patients have been observed for two years to study the influence of copaxone on clinical manifestations and course of their disease in relation to the state of membrane- destabilizing processes in erythrocytes.

Bibliographic Details
Main Authors: O. A. Kitcherova, L. I. Reikhert, S. M. Bychenko, A. A. Sokolova
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2008-09-01
Series:Bûlleten' Sibirskoj Mediciny
Subjects:
Online Access:https://bulletin.tomsk.ru/jour/article/view/3503